Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy

por Baumann, Daniel, Hägele, Tanja, Mochayedi, Julian, Drebant, Jennifer, Vent, Caroline, Blobner, Sven, Noll, Julia Han, Nickel, Irena, Schumacher, Corinna, Boos, Sophie Luise, Daniel, Aline Sophie, Wendler, Susann, Volkmar, Michael, Strobel, Oliver, Offringa, Rienk
Publicado 2020

A phase I trial of cyclosporine for hospitalized patients with COVID-19

por Blumberg, Emily A., Noll, Julia Han, Tebas, Pablo, Fraietta, Joseph A., Frank, Ian, Marshall, Amy, Chew, Anne, Veloso, Elizabeth A., Carulli, Alison, Rogal, Walter, Gaymon, Avery L., Schmidt, Aliza H., Barnette, Tiffany, Jurek, Renee, Martins, Rene, Hudson, Briana M., Chavda, Kalyan, Bailey, Christina M., Church, Sarah E., Noorchashm, Hooman, Hwang, Wei-Ting, June, Carl H., Hexner, Elizabeth O.
Publicado 2022